(Q42945779)

11 November 2017

0 references

Intensified glucose lowering in type 2 diabetes: time for a reappraisal (English)

1 reference

11 November 2017

1 reference

3

E A M Gale

1 reference

11 November 2017

J S Yudkin

1

1 reference

PubMed ID

20686748

11 November 2017

B Richter

series ordinal

2

1 reference

11 November 2017

5 August 2010

1 reference

11 November 2017

1 reference

11 November 2017

53

1 reference

11 November 2017

10

1 reference

11 November 2017

2079-2085

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-010-1864-z

11 November 2017

0 references

cites work

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1864-Z

The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1864-Z

The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1864-Z

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

12 December 2020

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Intensified glucose control in type 2 diabetes--whose agenda?

1 reference

12 December 2020

Estimated benefits of glycemic control in microvascular complications in type 2 diabetes

1 reference

12 December 2020

Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg

1 reference

12 December 2020

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

12 December 2020

Let's not turn elderly people into patients. Wanted: age adjusted outcomes

1 reference

12 December 2020

Patient perceptions of quality of life with diabetes-related complications and treatments

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Making sense of health statistics

1 reference

12 December 2020

W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators

1 reference

12 December 2020

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

1 reference

12 December 2020

Systematic review: glucose control and cardiovascular disease in type 2 diabetes

1 reference

12 December 2020

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort

1 reference

12 December 2020

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

12 December 2020

How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects

1 reference

12 December 2020

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

12 December 2020

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Prevalence of comorbidity of chronic diseases in Australia

1 reference

12 December 2020

The impact of prevention on reducing the burden of cardiovascular disease

1 reference

12 December 2020

Intensive glucose control and cardiovascular outcomes

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?

1 reference

12 December 2020

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

1 reference

12 December 2020

The treatment of pneumococcic meningitis with penicillin; a study of 125 consecutive cases, with 73% recovery

1 reference

12 December 2020

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

12 December 2020

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

12 December 2020

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

12 December 2020

C-reactive protein and coronary heart disease: predictive test or therapeutic target?

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Three-year efficacy of complex insulin regimens in type 2 diabetes

1 reference

12 December 2020

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

12 December 2020

10.1007/S00125-010-1864-Z

Identifiers

DOI

1 reference

11 November 2017

1 reference

PubMed ID

20686748